Compare SMBC & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SMBC | CTKB |
|---|---|---|
| Founded | 1887 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 764.5M | 777.3M |
| IPO Year | 2011 | 2021 |
| Metric | SMBC | CTKB |
|---|---|---|
| Price | $72.25 | $5.76 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $78.40 | $6.17 |
| AVG Volume (30 Days) | 70.8K | ★ 1.4M |
| Earning Date | 10-21-2026 | 11-04-2026 |
| Dividend Yield | ★ 1.53% | N/A |
| EPS Growth | ★ 24.13 | N/A |
| EPS | ★ 6.43 | N/A |
| Revenue | N/A | ★ $193,015,000.00 |
| Revenue This Year | $4.94 | $3.82 |
| Revenue Next Year | $3.20 | $6.49 |
| P/E Ratio | $11.03 | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $52.52 | $3.31 |
| 52 Week High | $79.86 | $6.34 |
| Indicator | SMBC | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 54.35 | 53.98 |
| Support Level | $69.90 | $4.17 |
| Resistance Level | $78.94 | $6.21 |
| Average True Range (ATR) | 1.43 | 0.28 |
| MACD | 0.24 | 0.04 |
| Stochastic Oscillator | 71.10 | 48.91 |
Southern Missouri Bancorp Inc is a USA-based holding company for Southern Missouri Savings Bank. The principal business of the bank consists of attracting retail deposits from the general public and using such deposits along with wholesale funding from the Federal Home Loan Bank of Des Moines, and to a lesser extent, brokered deposits, to invest in one- to four-family residential mortgage loans, mortgage loans secured by commercial real estate, commercial non-mortgage business loans, and consumer loans. It is engaged in providing the range of banking and financial services to individuals and corporate customers in its market areas. The company derives revenue principally from interest on loans, debt securities, bank card interchange fees, loan late charges and another fee income.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.